Navigation Links
Nexavar Significantly Extends Survival of Liver Cancer Patients

CHICAGO, Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc. today announced that Nexavar(R) (sorafenib) tablets significantly extended overall survival in patients with hepatocellular carcinoma (HCC), or primary liver cancer versus those taking placebo by 44%. Results were presented at the 43rd annual meeting of the American Society of Clinical Oncology (ASCO).

The international, Phase 3, placebo-controlled Sorafenib HCC Assessment Randomized Protocol (SHARP) Trial randomized and evaluated 602 liver cancer patients who had no prior systemic therapy at sites in the Americas, Europe, and Australia/New Zealand. The primary objective of the study was to compare overall survival in patients administered Nexavar versus those administered placebo.

Median overall survival was 10.7 months in Nexavar-treated patients compared to 7.9 months in those taking placebo."Because there are no therapies that significantly improve survival for the thousands of patients with liver cancer, these findings demonstrate the compelling study results of Nexavar as the new reference standard of care for the first-line treatment of HCC," said Dr. Josep M. Llovet, co-principal investigator and Professor of Research, Barcelona Clinic Liver Cancer (BCLC) Group, IDIBAPS, Liver Unit, Hospital Clinic Barcelona; Director of Research, HCC Program, Associate Professor of Medicine, Mount Sinai School of Medicine, New York.Bayer and Onyx halted the SHARP trial in February 2007 when an independent data monitoring committee determined in a pre-scheduled analysis that the overall survival endpoint had been met.

There were no significant differences in serious adverse event rates between the Nexavar and placebo-treated groups, with the most commonly observed serious adverse events in patients receiving Nexavar being diarrhea and hand-foot-skin reaction. Based on the strength of the data, the companies are now in the process of preparing applications
'"/>




Page: 1 2

Related medicine news :

1. Violence at Work Significantly Boosts Clinical Depression Risk
2. Computer-Driven System Reduces Patient Mechanical Ventilation Time Significantly
3. New Study: Pine Bark Significantly Reduces Endometriosis
4. STIs Significantly Increase Risk of Drug-resistant HIV Transmission
5. Masimo SET Pulse Oximetry Technology Significantly Reduce the Risk of ROP
6. Intensity of Rheumatoid Arthritis Significantly Reduced by Pregnancy
7. Irish Medicines Board Extends Paracetamol Recall To All Batches
8. Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
9. Caloric Restriction in Non-obese People Extends Life Span
10. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
11. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nexavar Significantly Extends Survival Liver Cancer Patients

(Date:10/1/2014)... 2014 Anti Aging Clinic (AntiAgingClinic.ca), the ... destination of choice, is announcing a discounted cost on ... December. , “We’re doing this because we want to ... top skin clinic in Toronto,” says Dr. Brian Sieber, ... at Anti Aging Clinic, including laser facials, genesis laser ...
(Date:10/1/2014)... in Bahir Dar, Ethiopia, at the occasion of ... gathered some 150 African and international leishmaniasis experts, ... safety and efficacy monitoring plan, carried out ... Sudan, Uganda, and Ethiopia, were presented to key ... to treatment of kala-azar with the combination of ...
(Date:10/1/2014)... October 01, 2014 Woodland Hills ... to a group of dental specialists who treat full ... Spain city of Oviedo. Dr. Reshad of the Anacapa ... with clients on two continents, will give a full-day ... full mouth reconstruction. , “These specialists want to improve ...
(Date:10/1/2014)... WA (PRWEB) October 01, 2014 Two ... will take them across the country in an effort ... today’s military families. The cyclists, a father-daughter team, ... states, beginning in Blaine, Washington and finishing in Key ... benefit Hope For The Warriors®, a national nonprofit organization ...
(Date:10/1/2014)... 2014 UP4 Probiotics will be donating ... to The National Network to End Domestic Violence ( ... was chosen through nationwide polling that took place during ... outlets. , “We are proud to have been ... every sale of UP4 Women’s Probiotics during the month ...
Breaking Medicine News(10 mins):Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2
... , , , ... David Letterman joined Ronald O. Perelman, chairman of MacAndrews & ... Herbert Pardes at a ceremony today officially opening the new ... Center, an innovative center offering comprehensive, world-class cardiovascular care and ...
... , SCHAUMBURG, Ill., Sept. 14 More than ... Yet when detected early, skin cancer has a cure rate of 99 ... of Dermatology,s National Melanoma/Skin Cancer Screening Program conducted free skin cancer screenings ... , "With its emphasis on agriculture, the fair provided ...
... ... at Leading IP Communications Conference in Los Angeles , ... Tigard, Ore. (Vocus) September 14, 2009 -- FaxBack®, a leading provider ... its VoIP Plug-In for Microsoft Fax received a "Best of Show Award" in the SMB ...
... , , , ... announced today the results of its Phase 2b Dextofisopam clinical trial ... syndrome. , , Although the primary efficacy ... symptoms) did not reach statistical significance, the percentage responding for the ...
... Advocates to Meet with 40 Key Congressional Committee ... WASHINGTON, Sept. 14 This week, the Coalition for Pulmonary ... Week. The official dates are September 14-21. In the more ... staffers, the CPF will be advocating for passage of the Pulmonary Fibrosis ...
... Inc. (OTC BB: ALRX). Speaking at the 11th Annual ... City, AlphaRx Director Dr. David Milroy presented a company ... delivery platform and the significant developments anticipated within the ... products in different stages of clinical development by the ...
Cached Medicine News:Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 2Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 3Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 4Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 5Health News:Dermatologists Screen More Than 1,300 People for Skin Cancer at Kentucky State Fair 2Health News:Dermatologists Screen More Than 1,300 People for Skin Cancer at Kentucky State Fair 3Health News:FaxBack Awarded "Best of Show" at ITEXPO West 2009 2Health News:FaxBack Awarded "Best of Show" at ITEXPO West 2009 3Health News:Pharmos Announces Results of Phase 2b Irritable Bowel Syndrome Study 2Health News:Pharmos Announces Results of Phase 2b Irritable Bowel Syndrome Study 3Health News:CPF Holds Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Holds Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Holds Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:AlphaRx Presents Company Overview and New Product Candidates at the Rodman Renshaw Healthcare Conference 2
(Date:10/1/2014)... BOSTON , Oct. 1, 2014   ... market-leading provider of Anesthesia Information Management Systems (AIMS), ... Systems, LLC , a wholly owned subsidiary of ... healthcare information systems and connectivity solutions.  ... http://photos.prnewswire.com/prnh/20140930/149407 This partnership ...
(Date:10/1/2014)... NeuroCall, Inc., ("NeuroCall") announced today that it ... Teleneurology services. Dr. Ricardo Garcia-Rivera , Founder and ... proud that our quality of service has been recognized ... lifesaving support and continuity of care to patients of ... the United States ." NeuroCall ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3NeuroCall Awarded Joint Commission Accreditation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3
... 2011 Smith & Nephew Orthopaedics (NYSE: ... agreement with French biotechnology company Graftys. The deal gives ... calcium phosphate bone void filler in the U.S., and ... "We are committed to offering our surgeon customers innovative ...
... (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, ... ended March 31, 2011. In the ... increased $1,031,003 to $2,284,552, up 82% compared to the ... strength in its prescription business and the acquisition of ...
Cached Medicine Technology:Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 2Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 3HealthWarehouse.com Reports 82% Quarter-Over-Quarter Revenue Growth in the First Quarter 2011 2
... LH 755 simplifies and automates ... expert automation and advanced technologies ... reliable, accurate results every time. ... slide quality with its slide-on-slide ...
Kinetic and endpoint methods for the quantitative determination of creatinine in serum....
For the quantitative determination of creatine kinase-MB in serum. Kinetic Reaction measured at 340 nm. Linearity: 700 IU/L at 37C....
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents....
Medicine Products: